Hofseth BioCare ASA
Sümbol: HBC.OL
OSL
2.09
NOKTuruhind täna
-7.7400
P/E suhe
0.0000
PEG suhe
825.72M
MRK Cap
- 0.00%
DIV tootlus
Hofseth BioCare ASA (HBC-OL) Finantsaruanded
Bilanss
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 23.9 | 29.9 | 47.2 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -1 | 0 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 14.8 | 14.1 | 32.3 | ||||||||||||||
balance-sheet.row.inventory | 0 | 82.5 | 116.5 | 90.8 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 9.7 | 12.7 | 0 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 131 | 175.7 | 170.3 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 165.7 | 168.8 | 185.8 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 55.3 | 60.6 | 53.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 55.3 | 60.6 | 53.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 38.1 | 6.9 | 6.8 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -6.9 | -6.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 5.9 | 6.7 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 259.1 | 235.3 | 245.7 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 390.1 | 411 | 416 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 55.2 | 145.8 | 124.2 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 39.7 | 13.4 | 14.5 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 97.1 | 90.8 | 124.7 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 157 | 13.1 | 12.2 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 97.1 | 90.8 | 124.7 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 96.8 | 102.8 | 113 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 349 | 263 | 275.6 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 4 | 4 | 3.6 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | 37.9 | 145.7 | 0 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | -1 | 137.5 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 41.8 | 148.7 | 141.1 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 390.1 | 411 | 416 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | -0.7 | -0.7 | -0.7 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 41.1 | 148 | 140.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 38.1 | 5.9 | 6.8 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 136.8 | 104.2 | 139.2 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 112.9 | 74.3 | 92 |
Rahavoogude aruanne
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -106.7 | -137.4 | -126.5 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 36.4 | 30.4 | 29.4 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 77.4 | 52.1 | 26 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -0.8 | -4 | 4.2 | ||||||||||||||
cash-flows.row.inventory | 0 | 34 | -25.7 | -17.5 | ||||||||||||||
cash-flows.row.account-payables | 0 | 53.4 | 21.6 | 39.2 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -9.2 | 60.2 | 0.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -24.5 | 9.8 | 9.4 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -23.7 | -17.8 | -37.8 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | -0.2 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -0.2 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.2 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -23.7 | -17.8 | -37.9 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -32.6 | -2.4 | -3.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | -0.2 | 70.8 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -22.9 | -19.8 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 32.4 | 45.5 | -23.2 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -8.5 | -17.5 | -122.9 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 23.9 | 32.4 | 49.9 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 32.4 | 49.9 | 172.8 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -17.3 | -45.2 | -61.8 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -23.7 | -17.8 | -37.8 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | -40.9 | -62.9 | -99.5 |
Kasumiaruande rida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 190.8 | 120.4 | 87.6 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 245.4 | 91.9 | 64.5 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | -54.6 | 28.5 | 23.1 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | -6.1 | 1.6 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 71.6 | 157.1 | 141.7 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 317 | 249.1 | 206.2 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 0.6 | 0.7 | 0.6 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 7.5 | 10 | 9.4 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 16.9 | -8.8 | -7.9 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -6.1 | 1.6 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 16.9 | -8.8 | -7.9 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 7.5 | 10 | 9.4 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 36.4 | 30.4 | 29.4 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | -126.2 | -128.6 | -118.6 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | -109.2 | -137.4 | -126.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -2.5 | 1.2 | 1.5 | ||||||||||||||
income-statement-row.row.net-income | 0 | -106.7 | -137.4 | -126.5 |
Korduma kippuv küsimus
Mis on Hofseth BioCare ASA (HBC.OL) koguvara?
Hofseth BioCare ASA (HBC.OL) koguvara on 390119000.000.
Mis on ettevõtte aastane tulu?
Aastane tulu on N/A.
Mis on ettevõtte kasumimarginaal?
Ettevõtte kasumimarginaal on 0.076.
Mis on ettevõtte vaba rahavoog?
Vaba rahavoog on -0.086.
Mis on ettevõtte puhaskasumimarginaal?
Puhaskasumimarginaal on -0.552.
Mis on ettevõtte kogutulu?
Kogutulu on -0.507.
Mis on Hofseth BioCare ASA (HBC.OL) puhaskasum (puhaskasum)?
Puhaskasum (netotulu) on -106682000.000.
Kui suur on ettevõtte koguvõlg?
Koguvõlg on 136789000.000.
Mis on tegevuskulude arv?
Tegevuskulud on 71606000.000.
Milline on ettevõtte rahaline näitaja?
Ettevõtte raha on 0.000.